Multi-modality Imaging Identifies Key Times for Annexin V Imaging as an Early Predictor of Therapeutic Outcome
Radiolabeled annexin V may provide an early indication of the success or failure of anticancer therapy on a patient-by-patient basis as an in vivo marker of tumor cell killing. An important question that remains is when, after initiation of treatment, should annexin V imaging be performed. To addres...
Saved in:
Main Authors: | Stefanie J. Mandl, Carina Mari, Matthias Edinger, Robert S. Negrin, Jonathan F. Tait, Christopher H. Contag, Francis G. Blankenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2004-01-01
|
Series: | Molecular Imaging |
Online Access: | https://doi.org/10.1162/15353500200403157 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Breaching Biological Barriers: Protein Translocation Domains as Tools for Molecular Imaging and Therapy
by: Benjamin L. Franc, et al.
Published: (2003-10-01) -
Annexin V–CLIO: A Nanoparticle for Detecting Apoptosis by MRI
by: Eyk A. Schellenberger, et al.
Published: (2002-04-01) -
Annexin A5–Functionalized Nanoparticle for Multimodal Imaging of Cell Death
by: Rui Zhang, et al.
Published: (2013-05-01) -
Attenuation of Apoptosis by Telmisartan in Atherosclerotic Plaques of Apolipoprotein E Mice: Evaluation Using Technetium 99m–Annexin A5
by: Yan Zhao, et al.
Published: (2013-07-01) -
Advanced Imaging Modalities in the Detection of Cerebral Vasospasm
by: Jena N. Mills, et al.
Published: (2013-01-01)